Results 131 to 140 of about 362,184 (267)

Correction to: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 [PDF]

, 2022

openalex   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

Australian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt, K Thomas, S Page, J Norris, G Browning, C El Hage, A Stewart, J Gilkerson, G Muscatello, D Verwilghen, G van Galen, J Bauquier, R Cuming, B Reynolds, C Whittaker, E Wilkes, J Clulow, C Burden, L Begg   +18 more
wiley   +1 more source

Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

, 2020
Jia Gao, Liang Zhang, Xiaodan Liu, Fudong Li, Rongsheng Ma, Zhongliang Zhu, Jiahai Zhang, Jihui Wu, Yunyu Shi, Yueyin Pan, Yushu Ge, Ke Ruan   +11 more
openalex   +1 more source

Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 [PDF]

, 2020
Trine Gulholm, Kerri Basile, Jen Kok, S.C.-A. Chen, William D. Rawlinson   +4 more
openalex   +1 more source

Molecular Docking, Drug-Likeness and ADMET Analysis of Potential Inhibitors (Ligands) from Carica papaya Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

, 2020
Yosra A. Muhammad, Shehu Z Iliya S, Muhd BK Kani YA, Ahmad MB Wali U, MH Yeldu Tahiru A, Mohammed Y Ahmed AY, Yakubu A Habeeb A, Fatima IB Saeed, Abubakar UF   +8 more
openalex   +1 more source

Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients

, 2021
Alexandra T. Strauss, Andrew M. Hallett, Brian J. Boyarsky, Michael T. Ou, William A. Werbel, Robin K. Avery, Aaron A.R. Tobian, Allan B. Massie, James P. Hamilton, Jacqueline Garonzik‐Wang, Dorry L. Segev   +10 more
openalex   +2 more sources

Deep Learning Driven Drug Discovery: Tackling Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

, 2021
Yang Zhang, Taoyu Ye, Hui Xi, Mario Juhas, Junyi Li   +4 more
openalex   +1 more source

Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID‐19

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Adrenal incidentalomas (AI) are commonly found on imaging done for indications other than to assess the adrenal glands. Prevalence increases with age and is around 10% in people over 80 years. The majority of AIs are benign adenomas, with 20%−50% exhibiting mild autonomous cortisol secretion (MACS).
Alan Kelsall, Chris Johns, Eleanor Hills, Jenny Zhao, John Newell‐Price   +4 more
wiley   +1 more source

Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis [PDF]

, 2021
Mohammed Tarique, Shaban Ahmad, A.U. Malik, Irfan Ahmad, Mοhd Saeed, Ahmad Almatroudi, Talal Qadah, Manal Abdulaziz Murad, Mutaib M. Mashraqi, Qamre Alam, Yousef Al‐Saleh   +10 more
openalex   +1 more source

LL‐37 Inhibits TMPRSS2‐Mediated S2' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants

Cell Proliferation, EarlyView.
Cathelicidin LL‐37 inhibits SARS‐CoV‐2 by blocking the catalytic activity of TMPRSS2. The N764K mutation in the spike S2 subunit of Omicron variants confers resistance to LL‐37‐induced inhibition of TMPRSS2‐mediated S2' priming. ABSTRACT Continual evolution of SARS‐CoV‐2 spike drives the emergence of Omicron variants that show increased spreading and ...
Zhenfei Bi, Wenyan Ren, Hao Zeng, Yuanyuan Zhou, Jian Liu, Zimin Chen, Xindan Zhang, Xuemei He, Guangwen Lu, Yuquan Wei, Xiawei Wei   +10 more
wiley   +1 more source